IndraLab
Statements
sparser
"A recent study showed that ubiquitin-specific protease 29 (USP29) acts as a protective factor against metabolic dysfunction-associated steatotic liver disease (MASLD) progression by stabilizing long-chain acyl-CoA synthase 5 (ACSL5) and enhancing fatty acid β-oxidation, suggesting that the activation of the USP29–ACSL5 axis could represent a promising therapeutic strategy for MASLD [ xref ]."
sparser
"Together, in the present study, the regulatory effect of USP29-ACSL5 on the expression of genes involved in FAO may have occurred because, under metabolic stimulation, USP29 stabilized ACSL5 expression to promote the activation of fatty acids, which in turn activated PPARa to induce the expression of genes involved in FAO and then directed them to the mitochondria for β-oxidation."